2BB score and signals
Grace Therapeutics, Inc.’s current 2BB score is 17 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 34 | Weak |
| Quality | 20 | Weak |
| Risk | 46 | Moderate |
Grace Therapeutics, Inc. (GRCE) Stock Score & Signals
Grace Therapeutics, Inc. (GRCE) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 17 out of 100.
Company facts
| Founded | 2002 |
| Employees | 5 |
| 52-week range | $1.79 – $5.18 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-08-06 | — | -0.1326 | — | $0.00 |
| 2026-06-18 | -0.06 | -0.2346 | $0.00 | $0.00 |
| 2026-02-12 | -0.14 | -0.2856 | $0.00 | $0.00 |